Robert Kroslowitz appointed President and CEO Berlin Heart Inc.
Berlin Heart GmbH announced that Robert Kroslowitz, Vice President Clinical Affairs at Berlin Heart Inc. in The Woodlands, Texas, has been appointed President and CEO of the company’s North American Operations.
(firmenpresse) - Berlin Heart GmbH announced that Robert Kroslowitz, Vice President Clinical Affairs at Berlin Heart Inc. in The Woodlands, Texas, has been appointed President and CEO of the company’s North American Operations.
Robert Kroslowitz joined Berlin Heart in December 2005. Prior to joining Berlin Heart, Robert was employed as Director of Clinical Operations and head of other established corporations. He also possesses longstanding clinical and research experience in the cardiovascular space having served as director of several clinical departments in well-known US medical centers. Since joining Berlin Heart, he has significantly contributed to building the US operations, the development of the North American market and has played a leading role in the FDA approval process, which the company is running for its pediatric heart assist device “EXCOR® Pediatric” in the US. With his enormous knowledge, his operational abilities and his tireless work for patients suffering from heart failure, Berlin Heart chose to appoint him as the new CEO. In his new position he will take over the complete management of the US business.
“We are proud that we were able to win Robert for this position and are convinced, that we will be able to further advance the success of our company with him” says Dr. Stefan Thamasett, CEO of Berlin Heart GmbH and Chairmen of the Board of Berlin Heart Inc, and to whom Robert will report in the future.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The devices INCOR®, EXCOR® Adult and EXCOR® Pediatric can support failing hearts short-, mid- and long-term and therefore offer a life-saving therapy. Customers moreover benefit from clinical and technical support by Berlin Heart VAD specialists who are available 7-24. INCOR®, and EXCOR® Adult are not FDA-approved, but widely used in Europe. The company is the market leader in Germany and Europe.
Berlin Heart
Wiesenweg 10
12247 Berlin
Germany
www.berlinheart.com
Datum: 14.10.2011 - 09:09 Uhr
Sprache: Deutsch
News-ID 1045985
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Berlin
Phone: + 49 (030) 81872600
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 175 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Robert Kroslowitz appointed President and CEO Berlin Heart Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Berlin Heart (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
